Mengullo, Reynold R.
HRN: 15-99-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2022
CEFTRIAXONE 1G (VIAL)
11/23/2022
11/30/2022
IV
2g
Q24
Removal Of Implant
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes